Onto Innovation is rated Buy, supported by robust process-control demand in advanced semiconductor packaging and expanding product breadth. ONTO's Q2 revenue rose 35% YoY to $343M, with non-GAAP operating margin at 30% and EPS at $1.93; management guides for accelerating growth in H2. Backlog conversion, Dragonfly G5 adoption, and integration of Semilab USA and Rigaku partnerships are key to sustaining above-market earnings growth.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Onto Innovation (ONTO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Onto Innovation (ONTO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Onto Innovation's AI-driven demand, rising estimates and margin gains strengthen its outlook, but a rich valuation leaves little room for execution misses.
ONTO's $720M Rigaku stake adds X-ray process control to its portfolio, targeting a roughly $1B market as chip structures grow more complex.
Onto Innovation's 26.1% monthly rally is backed by record revenue, a $1.1B-plus backlog and raised guidance, but rich valuation raises the execution bar.
Onto Innovation (ONTO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Onto Innovation (ONTO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Review Onto Innovation's (ONTO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Onto Innovation NYSE: ONTO reported second-quarter 2026 results above the high end of its guidance range, with revenue, margins and earnings supported by demand for semiconductor process-control systems used in advanced packaging and leading-edge chip manufacturing.
Onto Innovation Inc. delivered record Q2 results, with revenue up 35.3% Y/Y to $343.1 million and non-GAAP EPS of $1.93. I raised ONTO's H2 revenue growth outlook to 25% and advanced packaging guidance to 80%, citing strong AI-driven demand for Dragonfly G5 and Atlas G6 platforms. Backlog reached a record $1.1 billion, supporting continued growth and momentum; ONTO maintains a 'Buy' rating with industry-leading value and quant grades.